138 related articles for article (PubMed ID: 6178415)
1. Effect of L-glutamine antagonists on 5-phosphoribosyl 1-pyrophosphate levels in P388 leukemia and in murine colon adenocarcinomas in vivo.
Ardalan B; Arakawa M; Villacorte D; Jayaram H; Cooney DA
Biochem Pharmacol; 1982 Apr; 31(8):1509-13. PubMed ID: 6178415
[TBL] [Abstract][Full Text] [Related]
2. Phosphoribosyl pyrophosphate, pool size and tissue levels as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas.
Ardalan B; Villacorte D; Heck D; Corbett T
Biochem Pharmacol; 1982 Jun; 31(11):1989-92. PubMed ID: 6180752
[No Abstract] [Full Text] [Related]
3. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
4. Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.
Ardalan B; Chandrasekaran B; Hrishikeshavan HJ
Cancer Chemother Pharmacol; 1985; 15(1):44-8. PubMed ID: 2408773
[TBL] [Abstract][Full Text] [Related]
5. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
Huber KR; Rosenfeld H; Roberts J
Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
Lyons SD; Sant ME; Christopherson RI
J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
[TBL] [Abstract][Full Text] [Related]
7. Effect of uridine diphosphoglucose on levels of 5-phosphoribosyl pyrophosphate and uridine triphosphate in murine tissues.
Colofiore JR; Sawyer RC; Balis ME; Martin DS
Pharm Res; 1989 Oct; 6(10):863-6. PubMed ID: 2481854
[TBL] [Abstract][Full Text] [Related]
8. Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Ardalan B; Jayaram HN; Johnson RK
Cancer Res; 1983 Apr; 43(4):1598-601. PubMed ID: 6831405
[TBL] [Abstract][Full Text] [Related]
9. The concentration of 5-phosphoribosyl 1-pyrophosphate in monolayer tumor cells and the effect of various pyrimidine antimetabolites.
Peters GJ; Laurensse E; Leyva A; Pinedo HM
Int J Biochem; 1985; 17(1):95-9. PubMed ID: 2581824
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
11. Fluctuations in phosphoribosyl pyrophosphate levels in monolayer tumor cell lines. Effects of drugs.
Peters GJ; Laurensse E; Leyva A; Pinedo HM
FEBS Lett; 1984 May; 170(2):277-80. PubMed ID: 6202553
[TBL] [Abstract][Full Text] [Related]
12. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
Elliott WL; Howard CT; Dykes DJ; Leopold WR
Cancer Res; 1989 Oct; 49(20):5586-90. PubMed ID: 2477146
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
Houghton JA; Houghton PJ
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
[TBL] [Abstract][Full Text] [Related]
14. gamma-Glutamyl hydrolase from human sarcoma HT-1080 cells: characterization and inhibition by glutamine antagonists.
Waltham MC; Li WW; Gritsman H; Tong WP; Bertino JR
Mol Pharmacol; 1997 May; 51(5):825-32. PubMed ID: 9145921
[TBL] [Abstract][Full Text] [Related]
15. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
Cadman E; Benz C; Heimer R; O'Shaughnessy J
Biochem Pharmacol; 1981 Sep; 30(17):2469-72. PubMed ID: 21043247
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of combined therapy with methotrexate and 5-fluorouracil from the view point of cellular PRPP level of L1210 cells and HeLa S3 cells.
Kakuta H; Kanamaru R; Sato T; Ishioka C; Wakui A
Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):47-52. PubMed ID: 2428109
[No Abstract] [Full Text] [Related]
17. Induction of millimolar amounts of 5-phosphoribosyl-1-pyrophosphate in human erythrocytes by incubation in inosine-pyruvate-phosphate medium. A 31P-NMR study.
Petersen A; Quistorff B
Biomed Biochim Acta; 1990; 49(2-3):S111-6. PubMed ID: 1696811
[TBL] [Abstract][Full Text] [Related]
18. Characterization of L-threonine and L-glutamine transport in murine P388 leukemia cells in vitro. Presence of an N-like amino acid transport system.
Lazarus P; Panasci LC
Biochim Biophys Acta; 1986 Apr; 856(3):488-95. PubMed ID: 3083865
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
[TBL] [Abstract][Full Text] [Related]
20. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
Willis RC; Seegmiller JE
J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
